Green fluorescent protein (GFP)-labeled ovarian CSCs utilize the NANOG promoter system to overexpress OCT4, SOX2, and NANOG compared with the GFP-negative ovarian cancer cells, and the GFP-positive cells also exhibit greater cisplatin resistance and tumor initiation properties. This evidence concerns the gene NANOG and ovarian carcinoma.